Science Abstracts
Beneficial acute antidepressant effects of aripiprazole as an adjunctive treatment or monotherapy in bipolar patients unresponsive to mood stabilizers: results from a 16-week open-label trial
September 2010
September 2010
Authors : Marianna Mazza1 , Maria Rosaria Squillacioti1 , Riccardo Daniele Pecora2 , Luigi Janiri1 , Pietro Bria1
Affliation :
1Catholic University of Sacred Heart of Rome, Institute of Psychiatry and Psychology, Bipolar Disorders Unit, Via Ugo De Carolis, 48 00136 Roma, Italy ; ; ; mariannamazza@hotmail.com
2Polo Ospedaliero SS. Trinità, Sora, ASL Frosinone, Italy
DOI : 10.1517/14656560802504490
Published in : Expert Opin. Pharmacother.
Subject: Original research
Keywords: aripiprazole , bipolar disorder , depression , open label
Abstract
Please Login to read the full article.
RELATED CONTENT
NEWS
- GSK/Valeant's Potiga gets unanimous support from US FDA advisory panel
- EU's CHMP recommends Merck & Co's Sycrest for bipolar but not schizophrenia
- Medivation/Pfizer's disappointing Dimebon data sends Alzheimer's hopes, and shares, crashing
- HRA and Watson's emergency contraceptive ella approved in the US
COMMENT
Other Informa Comment
FEATURES
- Roche's Asian partnering head looks to tap regional innovation
- Connexios: Harnessing the Indian cost advantage in network biology
EVENTS
01 January 1970
London, UK
01 January 1970
San Diego, US
01 January 1970
Providence, Rhode Island, and San Francisco, California
JOB OF THE WEEK
Promote your vacancy here
